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ABSTRACT 
Aim 
To verify how variations in the height and solution density can influence syringe 
infusion pumps accuracy. 
Methods 
Three syringe infusion pumps were studied in two infusion rates 0.5ml/h and 
10.0ml/h. The solutions studied were saline solution and parenteral nutrition. The 
syringe infusion pumps were placed at the level of the distal exit of the infusion 
line, 30 cm above and 30 cm below.  
Results 
After two hours of infusion, loss of accuracy was verified mainly at 0.5 ml/h with 
a significant influence of infusion pump placement (p<0.001). At 10.0 ml/h there 
were differences between saline solution and parenteral nutrition at the same 
level (p<0.004) and 30cm above (p<0.001). After two hours of infusion the higher 
error rate identified was 20.1%. 
Conclusion 
The placement of the syringe infusion pump and the infusion rate influence 
accuracy mainly at 30 cm below and 0,5ml/h.  
 
Keywords: Infusion pumps; Syringe; Intensive Care; Medication Error; Patient 
Safety; Hydrostatic pressure; Neonatal.  
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INTRODUCTION 
Data from the United States of America (USA) show that about 100,000 patients 
dye per year because of medication errors that could be prevented.1 Patient 
safety is a global concern and medications errors are the major sources of severe 
adverse events. 
The associated healthcare spending related to medication errors has been 
estimated to be as high as 20 million dollars.2 Therefore, studies investigating 
medication errors are becoming relevant to increase the quality and safety of 
patient care delivery. 
 Pediatric and neonatal patients are one of the most affected group by 
medical errors, especially when admitted to an intensive care unit.3 This is due to 
the need of many different medications, immature body system and their inability 
to communicate symptoms.4 Around 57% of adverse events are considered as 
preventable errors and one of the most frequent are the dosing errors.5 
Administration via infusion pumps should ensure an accurate dose deliver.6  
Characteristics of each type of infusion pump should be known by 
clinicians in order to adequate its use to patients and therapeutic needs and 
prevent adverse events. In syringe infusion pumps the adjustment of the syringe 
size to the programmed volume of the infusion pump is a factor that improves the 
equipment performance. To achieve a steady flow rate when using a 60ml syringe 
in a low infusion rate as 0.2ml/h, the equipment requires almost an hour. When 
using a 3 or 12ml syringe the time drops for ten minutes, reducing the patient 
exposure to hemodynamics instability.7-8 
Hydrostatic pressure (P) is directly proportional to the fluid density (𝜌) and 
the vertical height (h) of the liquid column relative to a reference point and can 
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Hydrostatic pressure can influence the syringe infusion pumps accuracy. 9 
Changes on the placement of the syringe infusion pump, according to patient 
positions might have consequences on the accuracy of infusion flow due to 
pressure variations as it is a closed system. 9  Hydrostatic pressure is the strength 
made by a fluid to a surface, and it depends directly on the density of the fluid, 
the height of the infusion device and gravity force.9 The hydrostatic pressure in a 
closed infusion system is dependent on its characteristics and venous pressure.9 
Studies about syringe infusion pumps have demonstrated that changes on 
the infusion rate were related with hydrostatic pressure influence.10 One study 
documented that positioning the syringe infusion pump above the patient resulted 
in a drug bolus seven times higher than the rate set as 2 ml/h, and an increase in 
time for the equipment adaptation. When the pump was placed below the patient 
a temporary infusion interruption of around 180 seconds was observed. This 
temporary interruption was due to the fact that the pump had to overcome the 
pressure reduction at the exit of the infusion line caused by suddenly moving the 
pump to a position below the patient.10 
Current clinical practice in pediatric and neonatal Intensive Care Units 
(ICUs) is that syringe infusion pumps are widely used and not all equipment are 
positioned on the same level of the patient’s intravenous catheter, despite the 
type of solution infused. The search for patient safety and prevention of 
medication errors calls for further understanding of the accuracy of the infusion 
devices. Therefore, the aim of this study was to evaluate the performance of 
syringe infusion pumps on the variations in placement and density of the infused 
solution. 
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METHODS 
Type of Study  
An experimental study was deployed in a laboratory under controlled conditions 
of temperature and air humidity. All the equipment used were certificated and 
calibrated. The intravenous systems and solutions were sterile and adequate to 
the study requirements. Study approved by Research Ethics Committee of 
Federal University of São Paulo number 2091200916. 
Sample 
The sample was composed by results of 36 experimental infusions randomly 
study using three syringe infusion pumps, in two infusion rates, three equipment 
positioning and two solution densities.  
Experimental Design 
Three syringe infusion pumps from Samtronic® (model ST 6000, Brazil) were 
used. Two infusion rates were tested: 0.5ml/h and 10.0ml/h. The infusion pumps 
were positioned at three different placements: H1 the height at the same level of 
distal infusion system exit; H2 30cm above and H3 30cm below. 
To verify if the density of the solution influences the performance of the 
infusion pumps, two solutions were used being denominated as D1 the solution 
composed by 0.9% sodium chloride (normal saline) and D2 the parenteral 
nutrition composed by polyaminoacids, poliminerals, glucose and electrolytes.   
The solutions had their density and osmolality measured before the 
beginning of the infusion procedure. To verify the density, pycnometry technique 
was applied; 05 ml of each solution was collected and transferred to the 
pycnometer, glassware, and weighted through a Shimadzu® (model AUY220, 
Japan) analytic balance. The value found after the measure, was applied to a 
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mathematical formula corresponding to the density value. The density of D1 was 
0.98 – 1.00 g/cm3, and the D2 was 1.09 – 1.12 g/cm3. The osmolality of the 
solutions was verified by using the osmometer from PZL® (model PZL-1000, 
Brazil). With a syringe the D1 solution was collected in a 2.3ml cuvette that was 
submitted for analysis. The same procedure was performed with the D2 solution. 
The results were 0.224 – 0.296mOsmol for D1 solution and 1.613 – 
1.829mOsmol for D2. 
Once the density and osmolality of the solution were measured, a beaker 
was installed inside the analytical balance, and the next step was the execution 
of the experiments. The experimental infusion system is composed by a 20ml 
syringe filled with the solution and installed in the infusion pump, according to the 
randomization proposed. A three way stopcock and an IV tube 24 gauge were 
connected at the syringe. Another three-way stopcock was attached on the distal 
portion of the IV tube. The infusion pump was then positioned at the studied 
placement and an infusion rate was programmed. The filling of the IV tube was 
performed via the electronic bolus of the infusion pump.  
The infusion pumps remained in operation for two uninterrupted hours in 
order to obtain a better equipment performance.11Then the infusion was 
interrupted and the final volume was measured by Shimadzu® (model AUY220, 
Japan) analytic balance. The data was collected by the same professional during 
all the experiments. 
Data analysis 
The data obtained was expressed by mean and standard deviation, student’s t-
test and ANOVA test. Significance was set at a level of 0.05. 
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RESULTS 
We analyzed 36 experimental procedures, lasting two hours each, totaling 72 
hours of data collection.  
When studying the amount of infused volume in two hours of continuous 
infusion, the three positions studied demonstrated a significant influence with D1 
at rate 0.5 ml/h (p<0.001). There was no statistical difference between group D1 
and D2 at rate 0.5 ml/h. Although, with a rate of 10.0 ml/h statistical differences 
were found between group D1 and D2 according to the three positions (Table 1). 
Group D1 infused less than D2 at H1 (p=0.004), H2 (p=0.001) and H3 (p=0.018). 
 
Table 1. Total infused volume, in two hours, according to density, infusion rate 
and the syringe infusion pump placement.  
Legend: ml = milliliter; h = hour; SD = standard deviation 
 
 
Exit infusion line 
0.5 ml/h 
 
 10.0ml/h  
 Density I 
Mean 
(SD) 
Density II 
Mean (SD) 
Student-t test 
P 
Density I 
Mean (SD) 
Density II 
Mean (SD) 
 Student-t test 
P 
 
Same level as the 
infusion line exit 
(H1) 
 
 
 
 
0.866ml 
(0.003) 
 
 
0.867ml 
(0.091) 
 
 
 
0.985 
 
 
19.505ml 
(0.203) 
 
 
 
20.796ml 
(0.035) 
 
 
 
0.004 
30 cm above the 
infusion line 
exit(H2) 
 
 
 
0.927ml 
(0.125) 
 
 
0.961ml 
(0.064) 
 
 
 
0.695 
 
19.341ml 
(0.132) 
 
 
20.676ml 
(0.245) 
 
 
0.001 
30 cm below the 
infusion line 
exit(H3) 
 
 
 Anova test P 
value: 
 
 
0.799ml 
(0.033) 
 
 
 
<0.001 
 
0.881ml 
(0.080) 
 
 
 
 0.394 
 
0.716 
 
19.325ml 
(0.305) 
 
 
 
 0.584 
 
20.503ml 
(0.437) 
 
 
 
0.502 
 
0.018 
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Calculating the infusion error according to the total infused volume, the 
equipment evidenced inaccuracy. With a rate of 0.5 ml/h in D1 group, the syringe 
infusion pump had an error of 13.4% at H1, 7.3% at H2 and 20.1% at H3. 
Comparing to group D2, the error rates were of 13.3% at H1, 3.9% at H2 and 
11.9% at H3.  At a rate of 10.0 ml/h the equipment showed a rate error of 5%. 
 
DISCUSSION 
The performance of the syringe infusion pump is an important aspect to ensure 
patient safety and preventing medication errors. This study demonstrated an 
association of performance of syringe infusion pump, type of solution infused and 
positioning of the equipment. 
Critically ill patients are most affected by medication errors due to the vast 
use of drugs, such as vasoactive drugs in infusion pumps.11 The most important 
risk factors associated with the clinical use of syringe pumps includes overdose 
or under dose through the infusion of non-accurate amounts of drug leading to 
adverse events such as over sedation, respiratory depression, or significant 
fluctuations in blood pressure. 12 The pediatric population is the one that stands 
out most in the incidence rate of this type of error, because they need more 
precise doses and low infusion volumes.13 However, as this study found, the 
syringe infusion pumps lost its accuracy when a low infusion rate was settled and 
an extreme error rate of 20.1% was observed when the total volume infused was 
evaluated. 
After two hours of operation, it was identified that the syringe infusion 
pump, with an infusion rate of 0.5 ml/h, infused a volume lower than the 
programmed, in the three positions studied. Besides that, in all the experiments 
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with low rate, the equipment had an infusion error between 7.3% at H2 and 20.1% 
at H3 during the infusion of normal saline solutions. These infusion errors 
exceeded the maximum limit acceptable by the Brazilian Agency of Technical 
Standards (ABNT) of 5%.14 
The rate of errors found can be associated with the SIP mechanics. When 
the stepper motor turns the drive screw rotator, the equipment starts the infusion, 
and the fluid is delivered in a continuous way when a higher infusion rate is 
settled. When it is low, the infusion tends to be intermittent in regular bolus 
affecting the final volume delivered to the patient and its hemodynamics 
conditions.15 This affects the infusion flowrate and reflects on the patient 
hemodynamic and medication delivery.16 Another explanation can be given 
based on the intravenous sets compliance which can be affected by variations in 
hydrostatic pressure, such as equipment positioning and density of the infused 
solution.17 By lowering the infusion system, there is an increase in the pressure 
exerted on the distal infusion exit, causing the system to dilate and store more 
fluid.18 This results in less volume infused, explaining the higher infusion errors 
found when the equipment was positioned below the exit infusion line.  
Other study described that with an infusion rate below 1.0 ml/h, the 
variations in the positioning and density will be more likely to influence negatively 
on syringe infusion pumps performance.19 Evaluations regard the SIP placement 
also demonstrated that changing the placement of the equipment during its 
operation can cause an unexpected infusion interruption, explained by the 
equipment adjust due to changes in placement.20  
When the infusion solution contains any catecholamine, the 
recommendation of not change the SIP placement during its operation is 
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important. Case reports has shown that moving the equipment upwards to 80-
100 cm from the patient causes an unexpected infusion about 12 micrograms of 
epinephrine, increasing heart rate and blood pressure. Whereas if the patient is 
strongly dependent of catecholamine, is advised not to change the distance from 
the patient to the infusion device while its operation.21  
When choosing the use of syringe infusion pump, it is important that 
healthcare professionals be aware of the placement of the equipment at a low 
rate of infusion. More studies must be carried out in order to evaluate and 
measure the consequences of a poor accuracy of SIP in low rates on the patient. 
The findings of this research need to be returned to practice and ensures correct 
intravenous therapy, guarantying that the patient has a safety and optimal 
treatment. 
Implications for practice 
This study suggests that nurses and other healthcare professionals using infusion 
pumps must pay attention on syringe infusion pump placement. Areas of attention 
for safe practice when using infusion pumps in the pediatric population are the 
positioning of the equipment and infusion rate. When the infusion pump is placed 
below the patient, this will deliver less drug to the patient, mainly in low infusion 
rates. Changes on the flow-rate can occur and if the infused solution is a 
catecholamine or a multiple infusions system, the patient might be exposed to an 
unsafe practice causing errors with possible significant consequences.   
 
CONCLUSION 
The position of the syringe infusion pump can influence the amount of volume 
infused. The influence was more evident in low infusion rate. These variants 
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should be considered in intravenous therapy with syringe infusion pumps in 
pediatric patients, in order to reduce medication errors triggered by changes on 
hydrostatic pressure and the system compliance. Further investigations should 
be carried out in order to evaluate the use of unbending infusion system to reduce 
the compliance and if temperature or others variables can influence the system 
to expand.  
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